Home » Topics » BioWorld Science

BioWorld Science
RSS

Glaxo Wellcome/BioChem Pharma antitumor agent described at 211th ACS

April 19, 1996

FemPatch approval imminent in USA

April 19, 1996

FDA designates orphan drug for Peyronie's disease

April 19, 1996

Troglitazone NDA filing expected soon

April 19, 1996

YM-47813 revealed at 211th ACS

April 19, 1996

Taisho reports 5-HT4 agonists for GI disorders

April 19, 1996

FDA approves Prilosec + Biaxin combination for H. pylori

April 19, 1996

Byk Gulden researches anti-Helicobacter agents

April 19, 1996

FDA gives green light to Milkhaus for HP-4 clinical trial

April 19, 1996

SNAP-5399 presented at 211th ACS

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...